Filter
13817
Filtered Results: 13817
Text search:
needs
Featured
Recommendations
1129
New Publications
3421
Language
Document type
No document type
7592
Studies & Reports
2361
Guidelines
1488
Manuals
652
Fact sheets
485
Strategic & Response Plan
422
Training Material
274
Situation Updates
178
Infographics
120
Resource Platforms
79
Online Courses
69
Brochures
61
Videos
28
Dashboards/Maps
4
App
4
Countries / Regions
India
623
Global
572
Kenya
372
Sierra Leone
290
South Africa
281
Ethiopia
279
Nigeria
254
Liberia
253
Uganda
244
Nepal
242
Myanmar / Burma
235
Western and Central Europe
230
Syria
204
Africa
193
Bangladesh
186
Ukraine
183
Malawi
180
Latin America and the Carribbean
178
Rwanda
176
Zambia
174
Tanzania
164
Congo, Democratic Republic of
147
Ghana
141
Philippines
118
South Sudan
109
Namibia
97
Yemen
93
Haiti
92
Senegal
91
Zimbabwe
91
Germany
91
West and Central Africa
91
Mozambique
90
Indonesia
89
Guinea
84
South–East Asia Region
83
East and Southern Africa
83
Lesotho
82
Eastern Europe
82
Middle East and North Africa
75
Cambodia
73
Russia
73
Burkina Faso
71
Venezuela
69
Asia
67
Brazil
54
Cameroon
52
Lebanon
51
Eastern Europe and Central Asia
49
Afghanistan
48
Botswana
47
Central African Republic
41
Pakistan
41
Colombia
38
Mali
37
Sudan
33
Somalia
32
Eswatini/ Swaziland
32
Jordan
30
USA
29
Vietnam
29
Benin
28
Western Pacific Region
26
Côte d’Ivoire / Ivory Coast
25
Thailand
24
Madagascar
23
Tajikistan
22
Iraq
22
China
21
Niger
20
Turkey
19
Moldova
18
Angola
18
Peru
17
Sri Lanka
16
Albania
15
Laos
15
Palestine
14
Chad
14
United Kingdom
13
Georgia
13
Chile
12
Paraguay
12
Libya
12
North America
11
Argentina
11
Egypt
11
Greece
11
North Macedonia
10
Togo
10
Burundi
10
Southern Africa
10
Ecuador
10
Kazakhstan
9
Iran
9
Papua New Guinea
9
Malaysia
8
Guinea-Bissau
8
Mexico
7
Serbia
7
Kyrgyzstan
7
Italy
7
Jamaica
7
Romania
7
Poland
7
Bhutan
7
Timor Leste/ East Timor
6
Gambia
6
Hungary
6
Saudi Arabia
6
Portugal
6
Bolivia
6
El Salvador
5
Armenia
5
Turkmenistan
5
Tunisia
5
Spain
5
Canada
4
Fiji
4
Singapore
4
Estonia
4
Uzbekistan
4
Vanuatu
4
Japan
4
Honduras
4
Guatemala
4
Switzerland
3
Morocco
3
Mongolia
3
Mauritania
3
Croatia
3
Ireland
3
Mauritius
3
Belarus
3
Bosnia and Herzegovina
3
Djibouti
3
North Korea
2
Australia
2
Qatar
2
Bulgaria
2
Dominican Republic
2
Lithuania
2
Gabon
2
Denmark
2
Belgium
2
France
2
South Korea
2
Azerbaijan
2
Israel
2
Nicaragua
2
Slovakia
2
Austria
1
Maldives
1
Norway
1
Algeria
1
Morocco
1
French Guyana
1
Latvia
1
Barbados
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
4950
Clinical Guidelines
871
Public Health
692
Women & Child Health
686
Key Resources
626
Capacity Building
340
Pharmacy & Technologies
115
Annual Report MEDBOX
3
Toolboxes
COVID-19
1406
Mental Health
1081
HIV
952
Disability
614
TB
565
Planetary Health
505
Conflict
492
Ebola
462
Caregiver
403
Refugee
382
AMR
353
Rapid Response
347
NTDs
310
NCDs
296
Natural Hazards
239
Pharmacy
218
Global Health Education
216
Health Financing Toolbox
146
Social Ethics
109
Cholera
97
Zika
83
Specific Hazards
74
Polio
69
Typhoon
17
South Sudan
3
Health Financing
3
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19 vacci...
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co...
Trachoma, caused by particular serovars of Chlamydia trachomatis, is the leading
infectious cause of blindness. Infection is transmitted within ocular and nasal secretions that are passed from person to person on fingers, fomites (such as clothing) and eye-seeking flies (particularly Musca sorbens)...
Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas
Chagas disease caused by Trypanosoma cruzi is a public health issue in Latin America. This highly diverse parasite is divided into at least seven discrete typing units (DTUs) TcI-TcVI and Tcbat. Some DTUs have been associated with geographical distribution in epidemiological scenarios and clinical m...
Lymphatic filariasis (LF) infection if untreated results in fluid accumulation in the limbs or breasts (lymphedema) or genitalia (hydrocele) that is painful and causes great discomfort. Morbidity management and disability prevention (MMDP) strategies such as surgery for hydrocele, treatment of acute...
Two adjectives raise an issue for communicators working on Chagas disease (CD): “invisible and silent”. Two adjectives that can be ascribed to other neglected tropical diseases (NTD), but which are part of the essence of CD. Bringing CD out of its situation of neglect and oblivion is a mission e...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or...
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or drink.1-4 The...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field trial of a refined vector control tec...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
